Community
TrustFinance is not a licensed financial advisor and is not affiliated with any financial institutions in your region. Please do your own research before investing.
Lebanon
2014 (12 Years)
Last online: No recent activity
Be the first to rate and review this company.
Provided by TrustFinance
Be the first to rate and review this company.
TrustFinance is not a licensed financial advisor and is not affiliated with any financial institutions in your region. We encourage you to do your own research before making any investment decisions.
Warning
This company is currently Unproved.
Please be cautious of the potential risks!
License
A Grade License
Issued by globally renowned regulators, these licenses ensure the highest trader protection through strict compliance, fund segregation, insurance, and regular audits. Dispute resolution and adherence to AML/CTF standards further enhance security.
B Grade License
Granted by respected regional regulators, these licenses offer robust safety measures such as fund segregation, financial reporting, and compensation schemes. Though slightly less strict than Tier 1, they provide dependable regional protection.
C Grade License
Issued by regulators in emerging markets, these licenses offer basic protections such as minimum capital requirements and AML policies. Oversight is less stringent, so traders should exercise caution and verify safety measures.
D Grade License
From jurisdictions with minimal oversight, these licenses often lack key protections like fund segregation and insurance. While attractive for operational flexibility, they pose higher risks to traders.
TrustFinance is not a licensed financial advisor and is not affiliated with any financial institutions in your region. We encourage you to do your own research before making any investment decisions.
Get to know UbiQ Innovations
Company Information
Get to know UbiQ Innovations
UbiQ Innovations is a spin-off company of the Netherlands Cancer Institute (NKI-AVL) founded in 2010. The company focuses on the ubiquitin system, a key cellular process involved in protein degradation and signaling that is implicated in numerous human diseases, including cancer and neurodegenerative disorders. UbiQ Innovations develops and commercializes high-quality reagents, assays, and provides high-throughput screening services to support academic and pharmaceutical research, with the ultimate mission of facilitating the development of new medicines targeting the ubiquitin system.
Industry
Contact
-
-
-
-
Social
Company hasn't updated its information.
Reviews
Total 0
Filter
5 Star
4 Star
3 Star
2 Star
1 Star
Sort by
AI Review analysis
Let’s TrustFinance AI Summarize all the reviews for you.
Provided by TrustFinance AI Analysis
AI Review analysis
Let’s TrustFinance AI Summarize all the reviews for you.
Provided by TrustFinance AI Analysis